Real-World Efficacy and Safety of Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A Multicenter Retrospective Study From Turkey

Basit Öğe Kaydı
dc.contributor.authorBakirtas, Mehmet
dc.contributor.authorBerber, Lhami
dc.contributor.authorHindilerden, Ipek Yonal
dc.contributor.authorDal, Mehmet Sinan
dc.contributor.authorGuner, Sebnem Izmir
dc.contributor.authorUysal, Ayse
dc.contributor.authorAltuntasmd, Fevzi
dc.date.accessioned2026-08-12T17:40:15Z
dc.date.issued2025
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.urihttps://hdl.handle.net/11508/59201
dc.identifier.volume25
dc.identifier.wosWOS:001606306300023
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherCig Media Group, Lp
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemia
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCT
dc.subjectgraft-versus-host disease (GVHD)
dc.subjectruxolitinib
dc.subjectsteroid-refractory GVHD
dc.subjectallogeneic hematopoietic stem cell transplantation (allo-HSCT)
dc.subjectreal-world evidence
dc.titleReal-World Efficacy and Safety of Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A Multicenter Retrospective Study From Turkey
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu